MMP9 and cancer: MMP9 is the biomarker of osteoclast differentiation.24 Furthermore, qPCR was performed and substantial 67.9%–76.3% reductions in MMP9 transcription was observed from HOXC10 knockdown cancer cells conditioned medium induced osteoclasts (Fig. 3c).